Nabil Noureddin

1.0k total citations
29 papers, 538 citations indexed

About

Nabil Noureddin is a scholar working on Epidemiology, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nabil Noureddin has authored 29 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 16 papers in Hepatology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nabil Noureddin's work include Liver Disease Diagnosis and Treatment (19 papers), Liver Disease and Transplantation (12 papers) and Liver Diseases and Immunity (7 papers). Nabil Noureddin is often cited by papers focused on Liver Disease Diagnosis and Treatment (19 papers), Liver Disease and Transplantation (12 papers) and Liver Diseases and Immunity (7 papers). Nabil Noureddin collaborates with scholars based in United States, Singapore and Japan. Nabil Noureddin's co-authors include Mazen Noureddin, Naim Alkhouri, Jonathan M. Tobis, Emily Truong, Jeffrey Gornbein, Stephen A. Harrison, Ju Dong Yang, Rubine Gevorgyan, Rola Saouaf and Maha Guindi and has published in prestigious journals such as Journal of the American College of Cardiology, Hepatology and Stroke.

In The Last Decade

Nabil Noureddin

27 papers receiving 529 citations

Peers

Countries citing papers authored by Nabil Noureddin

Since Specialization

Citations

This map shows the geographic impact of Nabil Noureddin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nabil Noureddin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nabil Noureddin more than expected).

Fields of papers citing papers by Nabil Noureddin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nabil Noureddin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nabil Noureddin. The network helps show where Nabil Noureddin may publish in the future.

Co-authorship network of co-authors of Nabil Noureddin

This figure shows the co-authorship network connecting the top 25 collaborators of Nabil Noureddin. A scholar is included among the top collaborators of Nabil Noureddin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nabil Noureddin. Nabil Noureddin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Natural history of clinical outcomes and hepatic decompensation in metabolic dysfunction‐associated steatotic liver disease 2024 ·Alimentary Pharmacology & Therapeutics ·Nabil Noureddin, Daniel Q. Huang, Ricki Bettencourt, Harris Siddiqi, Abdul M. Majzoub, Tarek Nayfeh, Nobuharu Tamaki, Namiki Izumi, Atsushi Nakajima, Ramazan Idılman, Mesut Gümüşsoy, Diğdem Kuru Öz, Ayşe Erden, Tolga Gidener, Alina M. Allen, Veeral Ajmera, Rohit Loomba	5
2	Monitoring disease progression in metabolic dysfunction‐associated steatotic liver disease 2024 ·Alimentary Pharmacology & Therapeutics ·Nabil Noureddin, (unknown), Rohit Loomba	13
3	Low liver fat in non‐alcoholic steatohepatitis‐related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality 2023 ·Alimentary Pharmacology & Therapeutics ·Sung Won Lee, Daniel Q. Huang, Ricki Bettencourt, Veeral Ajmera, Monica A. Tincopa, Nabil Noureddin, (unknown), Harris Siddiqi, Egbert Madamba, Abdul M. Majzoub, Tarek Nayfeh, Nobuharu Tamaki, Namiki Izumi, Atsushi Nakajima, Masato Yoneda, (unknown), Mesut Gümüşsoy, Diğdem Kuru Öz, Ayşe Erden, Rohit Loomba	6
4	Increased accuracy in identifying NAFLD with advanced fibrosis and cirrhosis: independent validation of the Agile 3+ and 4 scores 2023 ·Hepatology Communications ·Mazen Noureddin, Edward Mena, Raj Vuppalanchi, Niharika Samala, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Nabil Noureddin, Anita Kohli, Stephen Harrison, Samer Gawrieh, Naim Alkhouri, Emily Truong	24
5	MRI-AST (MAST) Score Accurately Predicts Major Adverse Liver Outcome, Hepatocellular Carcinoma, Liver Transplant, and Liver-Related Death 2023 ·Clinical Gastroenterology and Hepatology ·Emily Truong, Jeffrey Gornbein, Ju Dong Yang, Nabil Noureddin, Stephen A. Harrison, Naim Alkhouri, Mazen Noureddin	21
6	Stratification of liver fat content in non-alcoholic steatohepatitis patients with significant liver fibrosis using the MEFIB-Index and MRI-PDFF and its association with hepatocellular carcinoma, decompensation, and mortality 2023 ·Journal of Hepatology ·Sung Won Lee, Daniel Q. Huang, Veeral Ajmera, Monica A. Tincopa, Jaclyn Bergstrom, Nabil Noureddin, (unknown), Harris Siddiqi, Egbert Madamba, Abdul M. Majzoub, Tarek Nayfeh, Nobuharu Tamaki, Namiki Izumi, Atsushi Nakajima, Ramazan Idılman, Mesut Gümüşsoy, (unknown), Ayşe Erden, Mazen Noureddin, Rohit Loomba	0
7	Noninvasive tests in the evaluation of nonalcoholic fatty liver disease: A review 2023 ·Clinical Liver Disease ·(unknown), Nabil Noureddin, Mazen Noureddin	5
8	MRI-based (MAST) score accurately identifies patients with NASH and significant fibrosis 2021 ·Journal of Hepatology ·Mazen Noureddin, Emily Truong, Jeffrey Gornbein, Rola Saouaf, Maha Guindi, Tsuyoshi Todo, Nabil Noureddin, Ju Dong Yang, Stephen A. Harrison, Naim Alkhouri	117
9	Progression of Nonalcoholic Fatty Liver Disease-Associated Fibrosis in a Large Cohort of Patients with Type 2 Diabetes 2021 ·Digestive Diseases and Sciences ·Nabil Noureddin, Mazen Noureddin, Amandeep Singh, Naim Alkhouri	14
10	MR elastography‐based liver fibrosis correlates with liver events in nonalcoholic fatty liver patients: A multicenter study 2020 ·Liver International ·Ma Ai Thanda Han, Aarshi Vipani, Nabil Noureddin, (unknown), Jeffrey Gornbein, Rola Saouaf, (unknown), (unknown), (unknown), Veronica Wendy Setiawan, Yaron Rotman, Rohit Loomba, Naim Alkhouri, Mazen Noureddin	63
11	Noninvasive Testing Using Magnetic Resonance Imaging Techniques as Outcomes in Nonalcoholic Steatohepatitis Clinical Trials: How Full Is the Glass? 2020 ·Hepatology Communications ·Nabil Noureddin, Jörn M. Schattenberg, Naim Alkhouri, Mazen Noureddin	12
12	MRI and AST (MAST) Score for Non-Invasive Identification of Patients with Non-Alcoholic Steatohepatitis with Significant Fibrosis 2020 ·Mazen Noureddin, Saleh A. Alqahtani, (unknown), (unknown), (unknown), Nabil Noureddin, (unknown), Nader Binesh, Rola Saouaf, Anita Kohli, Maha Guindi, Stephen A. Harrison, Naim Alkhouri	1
13	Comparison of residual shunt rate and complications across 6 different closure devices for patent foramen ovale 2019 ·Catheterization and Cardiovascular Interventions ·(unknown), Preetham Kumar, Brian West, Nabil Noureddin, (unknown), Jamil Aboulhosn, Jonathan M. Tobis	19
14	Coffee Drinking and Alcoholic and Nonalcoholic Fatty Liver Diseases and Viral Hepatitis in the Multiethnic Cohort 2017 ·Clinical Gastroenterology and Hepatology ·Veronica Wendy Setiawan, Jacqueline Porcel, Pengxiao C. Wei, Daniel O. Stram, Nabil Noureddin, Shelly C. Lu, Loı̈c Le Marchand, Mazen Noureddin	14
15	Percutaneous Closure of Patent Foramen Ovale or Atrial Septal Defect in the Presence of Thrombophilia 2017 ·(unknown), Nabil Noureddin, Jamil Aboulhosn, (unknown), (unknown), Jonathan M. Tobis	4
16	New Approach for Hybrid Stenting of the Aortic Arch in Low Weight Children 2017 ·(unknown), (unknown), (unknown), Nabil Noureddin, Jamil Aboulhosn, (unknown), (unknown), Jonathan M. Tobis, (unknown), Sara M. Trucco, Jaqueline Kreutzer, (unknown), (unknown), (unknown)	1
17	Usefulness of Transcranial Doppler for Detecting Pulmonary Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia 2016 ·The American Journal of Cardiology ·Yasufumi Kijima, Rubine Gevorgyan, Justin P. McWilliams, (unknown), Nabil Noureddin, Jonathan M. Tobis	6
18	TCT-738 The Degree of Right-to-Left Shunt is Associated with Visual Aura Due to Migraine 2015 ·Journal of the American College of Cardiology ·Yasufumi Kijima, (unknown), Nabil Noureddin, Rubine Gevorgyan, Jonathan M. Tobis	5
19	Sleep Apnea in Patients with and without a Right-to-Left Shunt 2015 ·Journal of Clinical Sleep Medicine ·Mohammad K. Mojadidi, (unknown), Rubine Gevorgyan, Nabil Noureddin, (unknown), (unknown), Ravi Aysola, Jonathan M. Tobis	26
20	CARDIAC CATHETERIZATION AND PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH END STAGE LIVER DISEASE 2015 ·Journal of the American College of Cardiology ·Nabil Noureddin, (unknown), Jonathan M. Tobis, (unknown), (unknown), William Suh, Henry M. Honda, Babak Azarbal, Randolph H. Steadman, Christopher Wray, Ronald W. Busuttil	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact